Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Dbv Technologies ADR (NQ: DBVT ) 0.6959 +0.0109 (+1.59%) Streaming Delayed Price Updated: 3:58 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Dbv Technologies ADR < Previous 1 2 3 4 5 6 7 Next > 12 Health Care Stocks Moving In Tuesday's Pre-Market Session February 20, 2024 Via Benzinga DBV Technologies And 2 Other Stocks Under $2 Insiders Are Buying February 09, 2024 The Dow Jones index closed higher by around 50 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF January 16, 2024 From DBV Technologies S.A. Via GlobeNewswire Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023 December 04, 2023 From DBV Technologies S.A. Via GlobeNewswire Top 5 Health Care Stocks That Could Blast Off In December December 01, 2023 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers November 09, 2023 From DBV Technologies S.A. Via GlobeNewswire Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023 November 06, 2023 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Present New Data at ACAAI 2023 November 02, 2023 From DBV Technologies S.A. Via GlobeNewswire Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket November 01, 2023 Gainers Via Benzinga DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results October 31, 2023 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update October 27, 2023 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer October 16, 2023 From DBV Technologies S.A. Via GlobeNewswire Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023 October 05, 2023 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Participate in Upcoming Investor Conference September 05, 2023 From DBV Technologies S.A. Via GlobeNewswire Stereotaxis And 3 Other Stocks Under $2 Insiders Are Aggressively Buying August 29, 2023 The Dow Jones closed higher by more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities DBV Technologies And 3 Other Penny Stocks Insiders Are Buying August 04, 2023 The Dow Jones closed lower by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session August 02, 2023 Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract. Via Benzinga Cambium Networks, SolarEdge Technologies, trivago And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session August 02, 2023 U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga DBV Technologies Advances Peanut Allergy Program With FDA Support On Pediatric Studies August 01, 2023 DBV Technologies (NASDAQ: DBVT) received Type C meeting written responses from the FDA on key study design elements for the COMFORT Toddlers and COMFORT Children supplemental safety studies in 1 –... Via Benzinga DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results July 31, 2023 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update July 25, 2023 From DBV Technologies S.A. Via GlobeNewswire Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023 July 19, 2023 From DBV Technologies S.A. Via GlobeNewswire Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF July 10, 2023 From DBV Technologies S.A. Via GlobeNewswire Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2023 June 16, 2023 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Participate in Upcoming EAACI Congress 2023 June 08, 2023 From DBV Technologies S.A. Via GlobeNewswire DBV Technologies to Participate in Upcoming Investor Conference June 06, 2023 From DBV Technologies S.A. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 17, 2023 Via Benzinga Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session May 15, 2023 Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash. Via Benzinga Why Shares of DBV Technologies Jumped Thursday May 11, 2023 The New England Journal of Medicine reported phase 3 trial details regarding the company's peanut allergy treatment for toddlers. Via The Motley Fool Good News For Toddlers With Peanut Allergy: DBVT Data Shows Promising Results for Peanut Allergy Patch May 11, 2023 DBV Technologies (NASDAQ: DBVT) (OTC: Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.